11:59 AM EST - The Hydropothecary Corporation : Reported its financial results for the three months ended April 30, 2018, the third quarter of the 2018 fiscal year. Revenue increased 5% to $1,240,172 and the volume of medical cannabis sold increased 2% to 134,253 gram equivalents from the second quarter of fiscal 2018. Loss came in at $1.97 million, much lower than the $11.8 million figures in the prior-year quarter. The Hydropothecary Corporation
shares T.HEXO are trading up $0.08 at $4.99.
